Patents by Inventor Vedpal S. Malik

Vedpal S. Malik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5684241
    Abstract: Nicotine acid sequences encoding a tobacco protein involved in nicotine synthesis are described. These sequences, when inserted in to sense or anti-sense orientation, affect nicotine synthesis in transgenic tobacco plants.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: November 4, 1997
    Assignee: Philip Morris Incorporated
    Inventors: Herbert Y. Nakatani, Vedpal S. Malik
  • Patent number: 5668295
    Abstract: Nicotine acid sequences encoding a tobacco protein involved in nicotine synthesis are described. These sequences, when inserted in to sense or anti-sense orientation, affect nicotine synthesis in transgenic tobacco plants.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: September 16, 1997
    Assignee: Philip Morris Incorporated
    Inventors: Samir Z. Wahab, Vedpal S. Malik
  • Patent number: 5369023
    Abstract: There is provided highly purified tobacco putrescine N-methyltransferase, a process for its purification, and production of PMT DNA sequence. The purification process includes the step of applying a tobacco root extract to an anion exchange medium and specifically eluting putrescine N-methyltransferase with an elution buffer comprising putrescine.
    Type: Grant
    Filed: August 9, 1993
    Date of Patent: November 29, 1994
    Assignee: Philip Morris Incorporated
    Inventors: Herbert Y. Nakatani, Vedpal S. Malik
  • Patent number: 5260205
    Abstract: There is provided highly purified tobacco putrescine N-methyltransferase, a process for its purification, and production of PMT DNA sequence. The purification process includes the step of applying a tobacco root extract to an anion exchange medium and specifically eluting putrescine N-methyltransferase with an elution buffer comprising putrescine.
    Type: Grant
    Filed: November 14, 1990
    Date of Patent: November 9, 1993
    Assignee: Philip Morris Incorporated
    Inventors: Herbert Y. Nakatani, Vedpal S. Malik
  • Patent number: 4685478
    Abstract: High temperature processes and thermophilic organisms for use in those processes for reducing the levels of certain nitrogen-containing compounds in tobacco materials. Tobacco materials are contacted with at least one thermophilic organism characterized by an anaerobic, dissimilatory, metabolic pathway for denitrification of tobacco materials under anaerobic and high temperature conditions that promote such metabolism. Tobacco materials treated in accordance with these high temperature processes and thermophilic organisms, when incorporated into a smoking product, deliver a significantly reduced amount of oxide of nitrogen in smoke. Moreover, such tobacco materials also afford the product of other tobacco products having lower amounts of nitrates and other nitrogen-containing compounds.
    Type: Grant
    Filed: October 1, 1981
    Date of Patent: August 11, 1987
    Assignee: Philip Morris Incorporated
    Inventors: Vedpal S. Malik, Bernard A. Semp, Hernan G. Bravo, Daniel M. Teng
  • Patent number: 4343906
    Abstract: A process for cloning DNA into a suitable host, which comprises fragmenting said DNA to obtain fragmented DNA, ligating said fragmented DNA into a suitable vector to obtain chimeric (hybrid) DNA, and transforming said chimeric DNA into said ultimate host. By this process, the useful chemical plasmid pUC3, which is obtainable from a biologically pure culture of the microorganism Streptomyces sp. 3022a, NRRL 11441, is cloned into the well-known bacterium E. coli HB101. This cloning of pUC3 into E. coli HB101 enables the production of large amounts of plasmid pUC3 DNA. pUC3 is useful as a cloning vehicle in recombinant DNA work. For example, using recombinant DNA methodology, a desired gene, for example, the insulin gene, can be inserted into pUC3 and the resulting plasmid can then be transformed into a suitable host microbe which, upon culturing, produces the desired insulin.
    Type: Grant
    Filed: August 21, 1979
    Date of Patent: August 10, 1982
    Assignee: The Upjohn Company
    Inventors: Fritz Reusser, Vedpal S. Malik
  • Patent number: 4271266
    Abstract: Microbiological process for preparing the antibiotic lincomycin at temperatures ranging from 18.degree. C. to 45.degree. C. using the newly discovered microorganism Streptomyces vellosus. The subject process advantageously results in the preparation of lincomycin without the concomitant production of lincomycin B (4'-depropyl-4'-ethyllincomycin). The absence of lincomycin B production results in increased lincomycin recovery efficiency.
    Type: Grant
    Filed: June 10, 1974
    Date of Patent: June 2, 1981
    Assignee: The Upjohn Manufacturing Company
    Inventors: Malcolm E. Bergy, John H. Coats, Vedpal S. Malik